Induction of Autophagy by Low Dose of Cisplatin in H460 Lung Cancer Cells

Background: Most lung cancer patients receive systemic chemotherapy at an advanced stage disease. Cisplatin-based chemotherapy is the main regimen for treating advanced lung cancer. Recently, autophagy has become an important mechanism of cellular adaptation under starvation or cell oxidative stress. The purpose of this study was to determine whether or not autophagy can occurred in cisplatin-treated lung cancer cells. Methods: H460 cells were incubated with RPMI 1640 and treated in 5 μM or 20 μM cisplatin concentrations at specific time intervals. Cells surviving cisplatin treatment were measured and compared using an MTT cell viability assay to cells that underwent apoptosis with autophagy by nuclear staining, apoptotic or autophagic related proteins, and autophagic vacuoles. The development of acidic vascular organelles was using acridine orange staining and fluorescent expression of GFP-LC3 protein in its transfected cells was observed to evaluate autophagy. Results: Lung cancer cells treated with 5 μM cisplatin-treated were less sensitive to cell death than 20 μM cisplatin-treated cells in a time-dependent manner. Nuclear fragmentation at 5 μM was not detected, even though it was discovered at 20 μM. Poly (ADP-ribose) polymerase cleavages were not detected in 5 μM within 24 hours. Massive vacuolization in the cytoplasm of 5 μM treated cells were observed. Acridine orange stain-positive cells was increased according in time-dependence manner. The autophagosome-incorporated LC3 II protein expression was increased in 5 μM treated cells, but was not detected in 20 μM treated cells. The expression of GFP-LC3 were increased in 5 μM treated cells in a time-dependent manner. Conclusion: The induction of autophagy occurred in 5 μM dose of cisplatin-treated lung cancer cells.

keywords: Autophagy, Cisplatin, Lung Neoplasms, Autophagy, Cisplatin, Lung Neoplasms

Reference

1. Levine B, Klionsky DJ. Development by self-digestion:molecular mechanisms and biological functions of autophagy. Dev Cell 2004;6:463-77.

2. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004;23:2891-906.

3. Schwarze PE, Seglen PO. Reduced autophagic activity,improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats.Exp Cell Res 1985;157:15-28.

4. Canuto RA, Tessitore L, Muzio G, Autelli R, Baccino FM. Tissue protein turnover during liver carcinogenesis.Carcinogenesis 1993;14:2581-7.

5. Kisen GO, Tessitore L, Costelli P, Gordon PB, Schwarze PE, Baccino FM, et al. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis 1993;14:2501-5.

6. Ahlberg J, Yucel T, Eriksson L, Glaumann H. Characterization of the proteolytic compartment in rat hepatocyte nodules. Virchows Arch B Cell Pathol Incl Mol Pathol 1987;53:79-88.

7. Yucel T, Ahlberg J, Glaumann H. Overall proteolysis in perfused and subfractionated chemically induced malignant hepatoma of rat: effects of amino acids. Exp Mol Pathol 1989;50:38-49.

8. Levine B. Cell biology: autophagy and cancer. Nature 2007;446:745-7.

9. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S,Sikorska M, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 1996;17:1595-607.

10.

10. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I.Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003;63:2103-8.

11.

11. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001;61:439-44.

12.

12. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S,Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003;98:378-84.

13.

13. Butler R, Mitchell SH, Tindall DJ, Young CY. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. Cell Growth Differ 2000;11:49-61.

14.

14. Fram RJ. Cisplatin and platinum analogues: recent advances. Curr Opin Oncol 1992;4:1073-9.

15.

15. Karantza-Wadsworth V, White E. Role of autophagy in breast cancer. Autophagy 2007;3:610-3.

16.

16. Levine B. Unraveling the role of autophagy in cancer.Autophagy 2006;2:65-6.

17.

17. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A,Maiuri MC, et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 2009;1793:1524-32.

18.

18. Levine B, Abrams J. p53: the Janus of autophagy? Nat Cell Biol 2008;10:637-9.

19.

19. Høyer-Hansen M, Jäättelä M. Autophagy: an emerging target for cancer therapy. Autophagy 2008;4:574-80.

20.

20. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 2007;3:28-31.

21.

21. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 2009;16:87-93.

22.

22. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ.Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007;6:304-12.

바로가기메뉴

Article Contents

Vol.69 No.1

Induction of Autophagy by Low Dose of Cisplatin in H460 Lung Cancer Cells

Abstract

Reference

Tuberculosis & Respiratory Diseases